FERMENTED TEA BEVERAGE AND TEA BEVERAGE

(19)

(11)

EP 1 854 363 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 2 (W2 B1)

(48)	Corrigendum issued on:
	23.02.2011 Bulletin 2011/08

(45)	Mention of the grant of the patent:
	28.07.2010 Bulletin 2010/30

(21)	Application number: 06714285.1

(22)	Date of filing: 22.02.2006

(51)

International Patent Classification (IPC):

A23F 3/00^(2006.01)

(86)	International application number:
	PCT/JP2006/303145

(87)	International publication number:
	WO 2006/090729 (31.08.2006 Gazette 2006/35)

(54)	FERMENTED TEA BEVERAGE AND TEA BEVERAGE FERMENTIERTES TEEGETRÄNK SOWIE TEEGETRÄNK BOISSON A BASE DE THE FERMENTE ET BOISSON A BASE DE THE

(84)	Designated Contracting States:
	CH DE ES FR GB IT LI NL

(30)

Priority:

23.02.2005 JP 2005047882

(43)	Date of publication of application:
	14.11.2007 Bulletin 2007/46

(73)	Proprietor: OTSUKA PHARMACEUTICAL CO., LTD.
	Chiyoda-ku Tokyo 101-8535 (JP)

(72)	Inventors:
	Endo, Rieko, Otsuka Pharmaceutical Co., Ltd. Tokushima 7710192 (JP) Wu, Po Sheng, Otsuka International Asia Arab Division Osaka-shi Osaka 5400021 (JP) Yamahira, Satoko, Otsuka Pharmaceutical Co., Ltd. Shiga 5200002 (JP) Toba, Masamichi, Otsuka Pharmaceutical Co., Ltd. Shiga 5200002 (JP) Okamatsu, Hiroshi, Otsuka Pharmaceutical Co., Ltd. Shiga 5200002 (JP)

(74)	Representative: HOFFMANN EITLE
	Patent- und Rechtsanwälte Arabellastraße 4 81925 München 81925 München (DE)

(56)

References cited: :

EP-A- 0 649 603
JP-A- 11 127 815
JP-A- 2002 080 364
JP-B2- 2 876 006

JP-A- 10 167 972
JP-A- 2001 064 174
JP-A- 2005 013 211

IKENAGA T. ET AL.: 'Enhancement of host resistance against Salmonella typhimurium in mice fed a diet supplemented with milk fermented with Lactobacillus plantarum' MILK SCIENCE vol. 51, no. 1, 2002, pages 27 - 32, XP002904110
MAO Y. ET AL.: 'Intestinal Immune Response to Oral Administration of Lactobacillus reuteri R2LC, Lactobacillus plantarum DSM 9843, Pectin and Oatbase on Methotrexate-induced Enterocolitis in Rats' MICROBIAL ECOLOGY IN HEALTH AND DISEASE vol. 9, no. 6, 1996, pages 261 - 269, XP002904111
BONET M. ET AL.: 'Optimal Effect of Lactobacillus delbrueecki subsp. bulgaricus, Among Other Lactobacilli Species, on the Number of IgA and Mast Cells Associated with the Mucosa in Immunosuppressed Mice' FOOD AND AGRICULTURAL IMMUNOLOGY vol. 11, no. 3, 1999, pages 259 - 267, XP002904112
HERIAS M.V. ET AL.: 'Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats' CLIN. EXP. IMMUNOL. vol. 116, no. 2, 1999, pages 283 - 290, XP002904113


	Remarks:
	The file contains technical information submitted after the application was filed and not included in this specification

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).